23.12.2013 • News • Dede Willams • Mergers & Acquisitions (M&A) • AZ Electronic Materials

Merck posts offer to acquire AZ Electronic Materials

In its $2.6 billion bid to acquire AZ Electronic materials, Germany's Merck KGaA posted the offer document to AZ shareholders on Dec. 20. The document contains the full terms and conditions along with the related form of acceptance. The AZ board has unanimously recommended acceptance.

The offer period will run until mid-February. Merck has offered £1.6 billion (nearly €2 billion) in cash for the Luxembourg-based firm, which manufactures anti-reflective coatings used in hard disc drives, as well as specialty chemicals for the graphic arts sector and shrink coatings used in memory devices. AZ had sales of $794 million (€584 million) in 2012.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Top-Feature

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.